Landscapes / Companies

Alkermes, Inc. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
ALKS 2680, Phase 2 trial completes
Drugs
3
in active trials · 6 in all
Trials
9 active
21 since 2021

Drugs3

DrugHow it worksPartnerStageNext dateDetails
—
Approved Sep 2027Phase 3 trial completes
—
Phase 3 Nov 2026soonPhase 2 trial completes
—
Phase 2 Jul 2027Phase 2 trial completes

About

No active trial
ALKS 1140, ALKS 5461, Samidorphan
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Alkermes, Inc.

Following is part of Solo: you see every change to Alkermes, Inc. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in